The New Pharmacotherapy of Schizophrenia
J Clin Psychiatry 1997;58(5):222 [book review]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
This book consists of 10 chapters authored by 19 leading researcher/ clinicians (18 M.D.s and 1 Ph.D.). All contributors are in the United States and from four states—Maryland, California, Connecticut, and New York. Dr. Breier, the Editor for this volume, is Chief of The Unit on Pathophysiology and Treatment, Experimental Therapeutics Branch, NIMH, in Bethesda, Maryland.